{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:59:42Z","timestamp":1790996382033,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T00:00:00Z","timestamp":1394150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000900","name":"CIRM","doi-asserted-by":"publisher","award":["DR2A-05320"],"award-info":[{"award-number":["DR2A-05320"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000971","name":"ALS","doi-asserted-by":"publisher","award":["LQLWE0"],"award-info":[{"award-number":["LQLWE0"]}],"id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.expneurol.2014.02.021","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T03:46:27Z","timestamp":1394163987000},"page":"127-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"PB","title":["The past, present and future of stem cell clinical trials for ALS"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-6378","authenticated-orcid":false,"given":"Gretchen M.","family":"Thomsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Gowing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soshana","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive N.","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.expneurol.2014.02.021_bb0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuron.2011.05.007","article-title":"Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone","volume":"70","author":"Aboody","year":"2011","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.expneurol.2014.02.021_bb0010","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.expneurol.2014.02.021_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/17482960802425559","article-title":"Is it too soon for mesenchymal stem cell trials in people with ALS?","volume":"9","author":"Badayan","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"issue":"2","key":"10.1016\/j.expneurol.2014.02.021_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/scd.2006.15.141","article-title":"Human mesenchymal stem cells express neural genes, suggesting a neural predisposition","volume":"15","author":"Blondheim","year":"2006","journal-title":"Stem Cells Dev."},{"issue":"5778","key":"10.1016\/j.expneurol.2014.02.021_bb0025","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boillee","year":"2006","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clinph.2012.08.022","article-title":"MUNIX and MUNE in ALS","volume":"124","author":"Bromberg","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2014.02.021_bb0035","first-page":"1","article-title":"Opportunities for improving therapy development in ALS","author":"Bruijn","year":"2014","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"issue":"5585","key":"10.1016\/j.expneurol.2014.02.021_bb0040","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1126\/science.297.5585.1299","article-title":"Failure of bone marrow cells to transdifferentiate into neural cells in vivo","volume":"297","author":"Castro","year":"2002","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.expneurol.2014.02.021_bb0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0166-2236(91)90158-Q","article-title":"Identifying and manipulating neuronal stem cells","volume":"14","author":"Cattaneo","year":"1991","journal-title":"Trends Neurosci."},{"issue":"5642","key":"10.1016\/j.expneurol.2014.02.021_bb0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","article-title":"Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice","volume":"302","author":"Clement","year":"2003","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.expneurol.2014.02.021_bb0055","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.2174\/1381612811319130015","article-title":"\u201cMesenchymal stem\/stromal cells: a new \u201ccells as drugs\u201d paradigm. Efficacy and critical aspects in cell therapy\u201d","volume":"19","author":"de Girolamo","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.expneurol.2014.02.021_bb0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2174\/156652412800619950","article-title":"Immunosuppressive properties of mesenchymal stem cells: advances and applications","volume":"12","author":"De Miguel","year":"2012","journal-title":"Curr. Mol. Med."},{"issue":"8","key":"10.1016\/j.expneurol.2014.02.021_bb0065","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0301-472X(00)00482-3","article-title":"Mesenchymal stem cells: biology and potential clinical uses","volume":"28","author":"Deans","year":"2000","journal-title":"Exp. Hematol."},{"issue":"12","key":"10.1016\/j.expneurol.2014.02.021_bb0070","doi-asserted-by":"crossref","first-page":"e80880","DOI":"10.1371\/journal.pone.0080880","article-title":"Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson's disease","volume":"8","author":"Deng","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.expneurol.2014.02.021_bb0075","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2007.09.022","article-title":"Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease","volume":"209","author":"Ebert","year":"2008","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.expneurol.2014.02.021_bb0085","doi-asserted-by":"crossref","first-page":"a015560","DOI":"10.1101\/cshperspect.a015560","article-title":"Mesenchymal stromal cells in transplantation rejection and tolerance","volume":"3","author":"English","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"70","key":"10.1016\/j.expneurol.2014.02.021_bb0090","first-page":"e4371","article-title":"\u201cSurgical technique for spinal cord delivery of therapies: demonstration of procedure in gottingen minipigs\u201d","author":"Federici","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3727\/096368908784153940","article-title":"Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients","volume":"17","author":"Ferrero","year":"2008","journal-title":"Cell Transplant."},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4067\/S0716-97602012000300008","article-title":"Mesenchymal stem cell treatment for autoimmune diseases: a critical review","volume":"45","author":"Figueroa","year":"2012","journal-title":"Biol. Res."},{"issue":"4","key":"10.1016\/j.expneurol.2014.02.021_bb0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13311-011-0082-9","article-title":"Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials","volume":"8","author":"Freed","year":"2011","journal-title":"Neurotherapeutics"},{"issue":"14","key":"10.1016\/j.expneurol.2014.02.021_bb0110","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1523\/JNEUROSCI.19-14-05990.1999","article-title":"Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain","volume":"19","author":"Fricker","year":"1999","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0115","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.clinph.2012.08.023","article-title":"MUNIX and incremental stimulation MUNE in ALS patients and control subjects","volume":"124","author":"Furtula","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2014.02.021_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev.ne.18.030195.001111","article-title":"Isolation, characterization, and use of stem cells from the CNS","volume":"18","author":"Gage","year":"1995","journal-title":"Annu. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0125","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","article-title":"Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS","volume":"117","author":"Ganesalingam","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2014.02.021_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-62703-574-3_6","article-title":"Culturing and expansion of \u201cclinical grade\u201d precursors cells from the fetal human central nervous system","volume":"1059","author":"Gelati","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jcp.20959","article-title":"From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells","volume":"211","author":"Giordano","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.expneurol.2014.02.021_bb0140","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/stem.1079","article-title":"Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients","volume":"30","author":"Glass","year":"2012","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.expneurol.2014.02.021_bb0145","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2014.02.021_bb0155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s13311-011-0068-7","article-title":"Stem cell transplantation for motor neuron disease: current approaches and future perspectives","volume":"8","author":"Gowing","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2014.02.021_bb0150","first-page":"1","article-title":"Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats","author":"Gowing","year":"2013","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/term.223","article-title":"Characterization of a human fetal spinal cord stem cell line, NSI-566RSC, and its induction to functional motoneurons","volume":"4","author":"Guo","year":"2010","journal-title":"J. Tissue Eng. Regen. Med."},{"issue":"10","key":"10.1016\/j.expneurol.2014.02.021_bb0165","doi-asserted-by":"crossref","first-page":"766","DOI":"10.5966\/sctm.2013-0049","article-title":"Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use","volume":"2","author":"Gutova","year":"2013","journal-title":"Stem Cells Transl. Med."},{"issue":"8","key":"10.1016\/j.expneurol.2014.02.021_bb0170","doi-asserted-by":"crossref","first-page":"e42614","DOI":"10.1371\/journal.pone.0042614","article-title":"Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation","volume":"7","author":"Hefferan","year":"2012","journal-title":"PLoS One"},{"issue":"5187","key":"10.1016\/j.expneurol.2014.02.021_bb0175","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.7973664","article-title":"GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle","volume":"266","author":"Henderson","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.expneurol.2014.02.021_bb0180","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/1545968306286976","article-title":"Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord","volume":"20","author":"Himes","year":"2006","journal-title":"Neurorehabil. Neural Repair"},{"issue":"6","key":"10.1016\/j.expneurol.2014.02.021_bb0185","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.stem.2008.11.009","article-title":"New ISSCR guidelines underscore major principles for responsible translational stem cell research","volume":"3","author":"Hyun","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.expneurol.2014.02.021_bb0190","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00001756-200004070-00023","article-title":"Redistribution of bisbenzimide Hoechst 33342 from transplanted cells to host cells","volume":"11","author":"Iwashita","year":"2000","journal-title":"Neuroreport"},{"issue":"9","key":"10.1016\/j.expneurol.2014.02.021_bb0195","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1523\/JNEUROSCI.5258-07.2008","article-title":"Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice","volume":"28","author":"Jaarsma","year":"2008","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.expneurol.2014.02.021_bb0200","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.expneurol.2010.12.010","article-title":"Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice","volume":"228","author":"Keller","year":"2011","journal-title":"Exp. Neurol."},{"issue":"9769","key":"10.1016\/j.expneurol.2014.02.021_bb0210","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.expneurol.2014.02.021_bb0215","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/hum.2005.16.509","article-title":"GDNF delivery using human neural progenitor cells in a rat model of ALS","volume":"16","author":"Klein","year":"2005","journal-title":"Hum. Gene Ther."},{"issue":"8","key":"10.1016\/j.expneurol.2014.02.021_bb0220","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/mt.2013.108","article-title":"Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model","volume":"21","author":"Krakora","year":"2013","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0225","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/nbdi.2002.0487","article-title":"Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Kriz","year":"2002","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.expneurol.2014.02.021_bb0230","doi-asserted-by":"crossref","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.expneurol.2014.02.021_bb0235","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s11481-013-9456-6","article-title":"\u201cTowards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system\u201d","volume":"8","author":"Laroni","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"6","key":"10.1016\/j.expneurol.2014.02.021_bb0240","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14653240310003611","article-title":"Immunomodulatory effects of fetal and adult mesenchymal stem cells","volume":"5","author":"Le Blanc","year":"2003","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.expneurol.2014.02.021_bb0250","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nn.2210","article-title":"Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease","volume":"11","author":"Lepore","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.expneurol.2014.02.021_bb0245","doi-asserted-by":"crossref","first-page":"e25968","DOI":"10.1371\/journal.pone.0025968","article-title":"Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS","volume":"6","author":"Lepore","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.expneurol.2014.02.021_bb0255","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(01)02384-9","article-title":"Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"316","author":"Li","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.expneurol.2014.02.021_bb0260","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0166-2236(91)90167-S","article-title":"Prospects of transplantation in human neurodegenerative diseases","volume":"14","author":"Lindvall","year":"1991","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1172\/JCI40543","article-title":"Stem cells in human neurodegenerative disorders\u2014time for clinical translation?","volume":"120","author":"Lindvall","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.expneurol.2014.02.021_bb0265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.stem.2012.01.009","article-title":"Clinical translation of stem cells in neurodegenerative disorders","volume":"10","author":"Lindvall","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/08977190902814855","article-title":"Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery","volume":"27","author":"Lunn","year":"2009","journal-title":"Growth Factors"},{"issue":"5","key":"10.1016\/j.expneurol.2014.02.021_bb0280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/17482968.2010.489116","article-title":"Stem cells and the ALS neurologist","volume":"11","author":"Maragakis","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.expneurol.2014.02.021_bb0285","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuroscience.2013.05.034","article-title":"Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model","volume":"248C","author":"Marconi","year":"2013","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0290","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/14653240802644651","article-title":"Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients","volume":"11","author":"Martinez","year":"2009","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0295","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/14660820310014653","article-title":"Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans","volume":"4","author":"Mazzini","year":"2003","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb9000","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.expneurol.2009.08.007","article-title":"Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A phase I clinical trial","volume":"223","author":"Mazzini","year":"2010","journal-title":"Exp Neurol"},{"issue":"5","key":"10.1016\/j.expneurol.2014.02.021_bb0305","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1179\/016164106X116791","article-title":"Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis","volume":"28","author":"Mazzini","year":"2006","journal-title":"Neurol. Res."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2014.02.021_bb0310","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2007.05.016","article-title":"Stem cell treatment in Amyotrophic Lateral Sclerosis","volume":"265","author":"Mazzini","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0300","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/14653249.2011.613929","article-title":"Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study","volume":"14","author":"Mazzini","year":"2012","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.expneurol.2014.02.021_bb0315","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12015-011-9260-8","article-title":"Stem cell tracking in human trials: a meta-regression","volume":"7","author":"McColgan","year":"2011","journal-title":"Stem Cell Rev."},{"issue":"12","key":"10.1016\/j.expneurol.2014.02.021_bb0320","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jocn.2013.04.024","article-title":"Stem cell therapy in amyotrophic lateral sclerosis","volume":"20","author":"Meamar","year":"2013","journal-title":"J. Clin. Neurosci."},{"issue":"Pt 7","key":"10.1016\/j.expneurol.2014.02.021_bb0325","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/brain\/awh510","article-title":"Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease","volume":"128","author":"Mendez","year":"2005","journal-title":"Brain"},{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2014.02.021_bb0330","doi-asserted-by":"crossref","first-page":"T133","DOI":"10.1016\/j.neuroimage.2008.06.017","article-title":"A chronic 1year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke","volume":"47","author":"Modo","year":"2009","journal-title":"Neuroimage"},{"issue":"12","key":"10.1016\/j.expneurol.2014.02.021_bb0335","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1109\/TBME.2004.834281","article-title":"Motor unit number index (MUNIX)","volume":"51","author":"Nandedkar","year":"2004","journal-title":"IEEE Trans. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.expneurol.2014.02.021_bb0340","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/rccm.201206-1072OC","article-title":"Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis","volume":"187","author":"Nichols","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0345","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/exnr.2000.7427","article-title":"Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation","volume":"164","author":"Ostenfeld","year":"2000","journal-title":"Exp. Neurol."},{"issue":"11","key":"10.1016\/j.expneurol.2014.02.021_bb0350","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1523\/JNEUROSCI.4184-10.2011","article-title":"Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G(9)(3)A transgenic ALS mice","volume":"31","author":"Ozdinler","year":"2011","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2014.02.021_bb0355","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.copbio.2009.09.003","article-title":"Advances in stem cell research for Amyotrophic Lateral Sclerosis","volume":"20","author":"Papadeas","year":"2009","journal-title":"Curr. Opin. Biotechnol."},{"issue":"5411","key":"10.1016\/j.expneurol.2014.02.021_bb0360","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"5309","key":"10.1016\/j.expneurol.2014.02.021_bb0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues","volume":"276","author":"Prockop","year":"1997","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0370","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/jnnp-2013-305494","article-title":"Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis","volume":"85","author":"Puentes","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0375","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.1097\/BRS.0b013e3181d77a47","article-title":"Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs","volume":"36","author":"Raore","year":"2011","journal-title":"Spine (Phila Pa 1976)"},{"issue":"10","key":"10.1016\/j.expneurol.2014.02.021_bb0380","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","article-title":"ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration","volume":"73","author":"Ravits","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.expneurol.2014.02.021_bb0385","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1227\/01.NEU.0000343524.45387.9E","article-title":"Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform","volume":"65","author":"Riley","year":"2009","journal-title":"Neurosurgery"},{"issue":"2 Suppl Operative","key":"10.1016\/j.expneurol.2014.02.021_bb0400","article-title":"\u201cPlatform and cannula design improvements for spinal cord therapeutics delivery\u201d","volume":"69","author":"Riley","year":"2011","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.expneurol.2014.02.021_bb0390","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1227\/NEU.0b013e31825ca05f","article-title":"Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes","volume":"71","author":"Riley","year":"2012","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0395","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1227\/NEU.0000000000000156","article-title":"\u201cIntraspinal stem cell transplantation in ALS: a phase I trial, cervical microinjection and final surgical safety outcomes\u201d","volume":"74","author":"Riley","year":"2014","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0405","first-page":"77","article-title":"\u201cElectrical impedance myography correlates with standard measures of Als severity\u201d","volume":"74","author":"Rutkove","year":"2014","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.expneurol.2014.02.021_bb0410","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/scd.2008.0411","article-title":"Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease","volume":"18","author":"Sadan","year":"2009","journal-title":"Stem Cells Dev."},{"issue":"2","key":"10.1016\/j.expneurol.2014.02.021_bb0415","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.expneurol.2011.12.045","article-title":"Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease","volume":"234","author":"Sadan","year":"2012","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0420","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2217\/rme.10.24","article-title":"Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders","volume":"5","author":"Sandrock","year":"2010","journal-title":"Regen. Med."},{"issue":"7205","key":"10.1016\/j.expneurol.2014.02.021_bb0425","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/454682a","article-title":"Neuroscience: standard model","volume":"454","author":"Schnabel","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0430","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17482960701856300","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"issue":"5","key":"10.1016\/j.expneurol.2014.02.021_bb0435","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2174\/1566524011313050016","article-title":"Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation","volume":"13","author":"Stagg","year":"2013","journal-title":"Curr Mol Med"},{"issue":"18","key":"10.1016\/j.expneurol.2014.02.021_bb0440","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.2174\/092986708785133031","article-title":"Biochemical markers in CSF of ALS patients","volume":"15","author":"Sussmuth","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.expneurol.2014.02.021_bb0450","doi-asserted-by":"crossref","first-page":"e689","DOI":"10.1371\/journal.pone.0000689","article-title":"GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS","volume":"2","author":"Suzuki","year":"2007","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.expneurol.2014.02.021_bb0445","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/mt.2008.197","article-title":"Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS","volume":"16","author":"Suzuki","year":"2008","journal-title":"Mol. Ther."},{"issue":"R1","key":"10.1016\/j.expneurol.2014.02.021_bb0455","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1093\/hmg\/ddt379","article-title":"Back to the future: how human induced pluripotent stem cells will transform regenerative medicine","volume":"22","author":"Svendsen","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.expneurol.2014.02.021_bb0460","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/exnr.1997.6634","article-title":"Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease","volume":"148","author":"Svendsen","year":"1997","journal-title":"Exp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2014.02.021_bb0465","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/17482960903511872","article-title":"ALSUntangled Update 3: investigating stem cell transplants at the Hospital San Jose Tecnologico de Monterrey","volume":"11","author":"The ALSUntangled Group","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2014.02.021_bb0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/21678421.2013.778554","article-title":"Mechanisms, models and biomarkers in amyotrophic lateral sclerosis","volume":"14","author":"Turner","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.expneurol.2014.02.021_bb0475","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2119\/molmed.2011.00498","article-title":"Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis","volume":"18","author":"Uccelli","year":"2012","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.expneurol.2014.02.021_bb0480","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/WCO.0b013e32835a3efb","article-title":"How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?","volume":"25","author":"van Blitterswijk","year":"2012","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.expneurol.2014.02.021_bb0485","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00001756-200206120-00018","article-title":"Minocycline delays disease onset and mortality in a transgenic model of ALS","volume":"13","author":"Van Den Bosch","year":"2002","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0490","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2008.05.016","article-title":"Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis","volume":"31","author":"Vercelli","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"Pt 6","key":"10.1016\/j.expneurol.2014.02.021_bb0495","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/brain\/awn071","article-title":"Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis","volume":"131","author":"Vucic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.021_bb0500","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.expneurol.2014.02.021_bb0505","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.yexcr.2006.03.012","article-title":"Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro","volume":"312","author":"Wright","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.expneurol.2014.02.021_bb0515","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.tp.0000235532.00920.7a","article-title":"Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats","volume":"82","author":"Xu","year":"2006","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0510","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neulet.2011.03.017","article-title":"Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats","volume":"494","author":"Xu","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"21","key":"10.1016\/j.expneurol.2014.02.021_bb0520","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0802556105","article-title":"Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice","volume":"105","author":"Yamanaka","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.expneurol.2014.02.021_bb0525","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.expneurol.2014.02.021_bb0530","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1634\/stemcells.2005-0518","article-title":"Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice","volume":"24","author":"Yan","year":"2006","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.expneurol.2014.02.021_bb0535","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pmed.0040039","article-title":"Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord","volume":"4","author":"Yan","year":"2007","journal-title":"PLoS Med."},{"issue":"6884","key":"10.1016\/j.expneurol.2014.02.021_bb0540","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.expneurol.2014.02.021_bb0545","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1474-4422(11)70024-2","article-title":"Emerging targets and treatments in amyotrophic lateral sclerosis","volume":"10","author":"Zinman","year":"2011","journal-title":"Lancet Neurol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T02:23:39Z","timestamp":1565231019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488614000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":110,"alternative-id":["S0014488614000739"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.02.021","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The past, present and future of stem cell clinical trials for ALS","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}